Risk factors for diabetic foot ulceration: A Logical approach to treatment

Journal of Wound, Ostomy and Continence Nursing

Volumn 25, Issue 3, 1998, Pages 123-128

  Armstrong, David G ^a,b   Lavery, Lawrence A ^a   Wunderlich, Robert P ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSIFICATION; DIABETIC FOOT; HOSPITALIZATION; HUMAN; METHODOLOGY; NURSING; NURSING ASSESSMENT; PATHOLOGY; REVIEW; RISK FACTOR;

DIABETIC FOOT; HUMANS; NURSING ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0032057190     PISSN: 10715754     EISSN: None     Source Type: Journal    
DOI: 10.1097/00152192-199805000-00005     Document Type: Article

References (36)

1. Armstrong DG, Lavery LA, van Houtum WH, Harkless LB. Seasonal variations in lower extremity amputation. J Foot Ankle Surg 1997;36:145-50.
2. Armstrong DG, Lavery LA, Quebedeaux TL, Walker SC. Surgical morbidity and the risk of amputation following infected puncture wounds of the foot in diabetic and non-diabetic adults. South Med J 1998;90:384-9.
3. Lavery LA, Ashry HR, van Houtum W, Pugh JA, Harkless LB, Basu S. Variation in the incidence and proportion of diabetes-related amputations in minorities. Diabetes Care 1998;19:48-52.
4. Wylie-Rosset J, Walker EA, Shamoon H, Engel S, Basch C, Zybert P. Assessment of documented foot examinations for patients with diabetes in inner-city primary care clinics. Arch Fam Med 1190-4:46-50.
5. Gibbons G, Eliopoulos GM. Infection of the diabetic foot. In: Kozak GP, Hoar CS, Rowbotham JL, editors. Management of diabetic foot problems. Philadelphia: WB Saunders;1984.p.97-102.
6. Pecoraro RE, Reiber GE, Burgess EM. Causal pathways to amputation: basis for prevention. Diabetes Care 1990;13:513-21.
7. Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes mellitus: a case control study. Ann Intern Med 1992;117:97-105.
8. Edelson GW, Armstrong DG, Lavery LA, Caicco G. The acutely infected diabetic foot is not adequately evaluated in an inpatient setting. Arch Intern Med 1996;156:2373-6.
9. National Diabetes Advisory Board. The national long-range plan to combat diabetes. Bethesda: National Institutes of Health; 1987.
10. Edmonds ME. Experience In a multidisciplinary diabetic foot clinic. In: Connor H, Boulton AJM, Ward JD, editors. The foot in diabetes. Chichester: John Wiley and Sons; 1987;121-31.
11. Lavery LA, van Houtum WH, Armstrong DG. Institutionalization following diabetes-related lower extremity amputation. Am J Med 1997;103:383-8.
12. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 1998;158:157-62.
13. Brand PW. The insensitive foot (including leprosy). In: Jahss M, editor. Disorders of the foot and ankle. 2nd ed. Philadelphia: WB Saunders;1991.p.2170-5.
14. Fernando DJS, Masson EA, Veves A, Boulton AJM. Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care 1991;14:8-11.
15. Rosenbloom AL, Silverstein JH, Lexotte DC. Limited joint mobility in childhood diabetics indicates increased risk for microvascular diseases. N Engl J Med 1982;305:191-4.
16. McNeely MJ, Boyko EJ, Ahroni JE, Stensel VL, Reiber GE, Smith DG, et al. The Independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. Diabetes Care 1995;18:216-9.
17. Birke JA, Sims DA. Plantar sensory threshold in the ulcerated foot. Lepr Rev 1986;57:261-7.
18. Young MJ, Breddy JL, Veves A, Boulton AJM. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. Diabetes Care 1994;16:557-60.
19. Armstrong DG, Todd WF, Lavery LA, Harkless LB. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. Diabetic Med 1997;14:357-63.
20. Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med 1998;158:289-92.
21. Armstrong DG, Lavery LA, Bushman TR. Peak foot pressures influence healing time of neuropathic ulcers treated with total contact casting. J Rehabil Res Dev 1998;35:1-5.
22. Cohen SJ. Potential barriers to diabetic care. Diabetes Care 1983;6:499-500.
23. Uccioli L, Faglia E, Monticone G, Favales F, Durola L, Aldeghi A, et al. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 1995;18:1376-8.
24. Strowig S, Raskin P. Glycemic control and diabetic complications. Diabetes Care 1992;15:1126-40.
25. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E. Effect of near normoglycemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J 1986;293:1195-9.
26. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependant diabetes mellitus. N Engl J Med 1993;329:966-86.
27. Reeves WG, Wilson RM. Infection, immunity, and diabetes. In: Alberti MM, DeFronzo RA, Kleen H, Zimmet P, editors. International textbook of diabetes mellitus. 1st ed. West Sussex: John Wiley and Sons; 1992.
28. Molinar DM, Palumbo PH, Wilson WR, Ritts RE. Leukocyte chemotaxis in diabetic patients and their first degree relatives. Diabetes 1976;25:880-9.
29. Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function In patients with poorly controlled diabetes. Diabetes 1974;23:9-17.
30. Tan JS, Anderson JL, Watanakunakorn D, Phair JP. Neutrophil dysfunction in diabetes mellitus. J Lab Clin Med 1975;85:26-33.
31. Sannomiya P, Preira MAA, Garcia-Lerne J. Inhibition of leukocyte chemotaxis by serum factor in diabetes mellitus: selective depression of cell responses mediated by complement-derived chemoattractants. Agents Actions 1990;30:369-76.
32. Larkin LG, Frier BM, Ireland JT. Diabetes mellitus and infection. Postgraduate Med J 1985;61:233-7.
33. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care 1992;15:1835-43.
34. Armstrong DG, Lavery LA, Harkless LB. Treatment-based classification system for assessment and care of diabetic feet. J Am Podiatr Med Assoc 1996;86:311-6.
35. Grayson ML, Balaugh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers: a clinical sign of underlying osteomyelitis in diabetic patients. JAMA 1995;273:721-3.
36. Caputo GM. Infection: investigation and management. In: Boulton AJM, Connor H, Cavanagh PR, editors. The foot In diabetes. 2nd ed. Chichester: Wiley and Sons; 1994.